Czech Republic – Medicinal product with the active ingredient complex of human plasma coagulation factor VIII and von Willebrand factor in a ratio of 1:1.2

By: University Hospital Brno📍 Czech RepublicOpen

Key Information

ReferenceGB-766810-2026
DeadlineDec 4, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressJihlavská 340, Brno, 62500, Czech Republic
PublishedNov 4, 2026

Description

2. Procedure2.1.ProcedureTitle: Medicinal product with the active ingredient complex of human plasma coagulation factor VIII and von Willebrand factor in a ratio of 1:1.2Description: The subject of th...

Full details are available after unlocking this tender.